Q5S007 (LRRK2_HUMAN) Homo sapiens (Human)
Leucine-rich repeat serine/threonine-protein kinase 2 UniProtKBInterProSTRINGInteractive Modelling
2527 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
36 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Cryo-EM structure of Rab29-LRRK2 complex in the LRRK2 dimer state |
Heteromer O14966; | 2×GDP; 2×ATP; | ||||
| Assess | ||||||
| Cryo-EM structure of Rab29-LRRK2 complex in the LRRK2 tetramer state |
Heteromer O14966; | 4×GDP; 4×ATP; | ||||
| Assess | ||||||
| Cryo-EM structure of Rab29-LRRK2 complex in the LRRK2 monomer state |
Heteromer O14966; | 1×MG; 1×GNP; 1×GDP; 1×ATP; | ||||
| Assess | ||||||
| Structure of full length LRRK2 bound to GZD-824 (I2020T mutant) |
Heteromer | 1×GDP; 1×T3X; | ||||
| Assess | ||||||
| Structure of full-length LRRK2 bound to MLi-2 (I2020T mutant) |
Heteromer | 1×A1N; 1×GDP; | ||||
| Assess | ||||||
| Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein Leucine Rich Rep… |
Heteromer | 1×GDP; 1×MG; | ||||
| Assess | ||||||
| Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein Leucine Rich Rep… |
Heteromer | |||||
| Assess | ||||||
| Structure of the C-terminal half of LRRK2 bound to GZD-824 (G2019S mutant) |
Heteromer | 1×T3X; | ||||
| Assess | ||||||
| Structure of C-terminal LRRK2 bound to MLi-2 (G2019S mutant) |
Heteromer | 1×A1N; 1×GDP; | ||||
| Assess | ||||||
| Structure of the C-terminal half of LRRK2 bound to GZD-824 (I2020T mutant) |
Heteromer | 1×T3X; | ||||
| Assess | ||||||
| Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS910 |
Heteromer P31947; | 4×CA; 2×CL; 2×NA; | ||||
| Assess | ||||||
| Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS935 |
Heteromer P31947; | 6×CA; 2×CL; | ||||
| Assess | ||||||
| Structure of the LRRK2 dimer | homo-2-mer | 2×GDP; 2×ATP; | ||||
| Assess | ||||||
| Cryo-EM structure of LRRK2 bound to type II inhibitor rebastinib | homo-2-mer | 2×GDP; 2×919; | ||||
| Assess | ||||||
| Cryo-EM structure of LRRK2 bound to type II inhibitor GZD824 | homo-2-mer | 2×GDP; 2×T3X; | ||||
| Assess | ||||||
| Cryo-EM structure of LRRK2 bound to type II inhibitor ponatinib | homo-2-mer | 2×0LI; 2×GDP; | ||||
| Assess | ||||||
| Integrative in situ structure of Parkinsons disease-linked human LRRK2 | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of LRRK2 WD40 domain dimer | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of LRRK2 WD40 domain dimer | homo-2-mer | 6×PT; | ||||
| Assess | ||||||
| Dimeric structure of LRRK2 GTPase domain | homo-2-mer | 4×MG; 2×GDP; | ||||
| Assess | ||||||
| Dimeric structure of LRRK2 GTPase domain | homo-2-mer | 4×MG; 2×GDP; | ||||
| Assess | ||||||
| 1.9A crystal structure of the GTPase domain of Parkinson's disease-associated protein LRRK2 carryin… | homo-2-mer | 2×MG; 2×GDP; | ||||
| Assess | ||||||
| Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 re… | homo-2-mer | 2×MG; 2×GDP; | ||||
| Assess | ||||||
| Structure of the LRRK2 monomer | monomer | 1×GDP; 1×ATP; | ||||
| Assess | ||||||
| Structure of the LRRK2 G2019S mutant | monomer | 1×GDP; 1×ATP; | ||||
| Assess | ||||||
| Structure of LRRK2 after symmetry expansion | monomer | 1×GDP; 1×ATP; | ||||
| Assess | ||||||
| Cryo-EM structure of LRRK2 bound to type I inhibitor LRRK2-IN-1 | monomer | 1×GDP; 1×4K4; | ||||
| Assess | ||||||
| Cryo-EM structure of LRRK2 bound with type-I inhibitor DNL201 | monomer | 1×GDP; 1×TVT; | ||||
| Assess | ||||||
| Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein Leucine Rich Rep… | monomer | |||||
| Assess | ||||||
| Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein Leucine Rich Rep… | monomer | 1×GDP; 1×MG; | ||||
| Assess | ||||||
| Structure of C-terminal LRRK2 bound to MLi-2 (I2020T mutant) | monomer | 1×A1N; 1×GDP; 1×MG; | ||||
| Assess | ||||||
| Structure of C-terminal LRRK2 bound to MLi-2 | monomer | 1×A1N; 1×GDP; | ||||
| Assess | ||||||
| Structure of C-terminal half of LRRK2 bound to GZD-824 | monomer | 1×T3X; | ||||
| Assess | ||||||
| Structure of Leucine Rich Repeat Kinase 2's ROC domain interacting with the microtubule facing the … | monomer | 1×GDP; | ||||
| Assess | ||||||
| Structure of Leucine Rich Repeat Kinase 2's ROC domain interacting with the microtubule facing the … | monomer | 1×GDP; | ||||
| Assess | ||||||
| Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 re… | monomer | 1×MG; 1×GDP; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8fo9.1.B | monomer | 0.74 | 1×GDP; 1×ATP; | 99.88 | ||
| Assess | ||||||
| 8fo8.1.C | monomer | 0.72 | 1×GDP; 1×ATP; | 99.88 | ||
| Assess | ||||||
| 6ojf.1.A | homo-2-mer | 0.65 | 2×MG; 2×GDP; | 92.15 | ||
| Assess | ||||||